GlenmarkPharma

{
  "lawp_version": "0.3",
  "domain": "glenmarkpharma.com",
  "name": "GlenmarkPharma",
  "language": "en",
  "pages": {
    "/": {
      "title": "Home - GlenmarkPharma",
      "content": "Redefining the boundaries of innovation Expanding the boundaries of accessibility At Glenmark, we are shaping the future of global health in a brave new world. A new world that requires us to formulate bold new ways by relentlessly pursuing a dual mission: pioneering transformative, innovative, breakthrough therapies that redefine treatment paradigms, and expanding access to […]"
    },
    "/oncology/": {
      "title": "Oncology",
      "content": "Oncology"
    },
    "/global-italy/": {
      "title": "Global \\- Italy",
      "content": "Global \\- Italy"
    },
    "/life-at-glenmark/": {
      "title": "Life at Glenmark",
      "content": "Life at Glenmark"
    },
    "/global-presence/global-europe/": {
      "title": "Global \\- Europe",
      "content": "Global \\- Europe"
    },
    "/quarterly_results/mda-q1-fy-27/": {
      "title": "MDA Q1 FY 27",
      "content": "MDA Q1 FY 27"
    },
    "/quarterly_results/earnings-call-recording-q1-fy27/": {
      "title": "Earnings Call Recording Q1 FY27",
      "content": "Earnings Call Recording Q1 FY27"
    },
    "/quarterly_results/earnings-call-transcript-q1-fy27/": {
      "title": "Earnings Call Transcript Q1 FY27",
      "content": "Earnings Call Transcript Q1 FY27"
    },
    "/press_release/glenmark-pharmaceuticals-announces-q1-fy27-results/": {
      "title": "Glenmark Pharmaceuticals Announces Q1 FY27 Results",
      "content": "Glenmark Pharmaceuticals Announces Q1 FY27 Results"
    },
    "/press_release/glenmark-expands-global-respiratory-innovation-footprint-with-ryaltris-launch-in-brazil/": {
      "title": "Glenmark Expands Global Respiratory Innovation Footprint with RYALTRIS® Launch in Brazil",
      "content": "Glenmark Expands Global Respiratory Innovation Footprint with RYALTRIS® Launch in Brazil"
    },
    "/press_release/glenmark-pharmaceuticals-receives-u-s-fda-approval-for-fluticasone-propionate-nasal-spray-0-05-mg-50-mcg-spray/": {
      "title": "Glenmark Pharmaceuticals receives U\\.S\\. FDA approval for Fluticasone Propionate Nasal Spray, 0\\.05 mg \\(50 mcg\\)/spray",
      "content": "Glenmark Pharmaceuticals receives U\\.S\\. FDA approval for Fluticasone Propionate Nasal Spray, 0\\.05 mg \\(50 mcg\\)/spray"
    }
  },
  "actions": [
    {
      "id": "search",
      "name": "Search the site",
      "input": {
        "type": "text",
        "required": true
      },
      "intent": [
        "search",
        "find",
        "look up"
      ],
      "description": "Search GlenmarkPharma"
    },
    {
      "id": "contact",
      "name": "Contact",
      "input": {
        "type": "text",
        "required": false
      },
      "intent": [
        "contact",
        "get in touch",
        "email",
        "message",
        "support"
      ],
      "description": "Get in touch with the site owner"
    }
  ]
}

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "LocalBusiness",
  "name": "GlenmarkPharma",
  "url": "https://glenmarkpharma.com",
  "telephone": "+00 0000 0000",
  "priceRange": "€€",
  "address": {
    "@type": "PostalAddress",
    "streetAddress": "Street 1",
    "postalCode": "0000",
    "addressLocality": "City",
    "addressCountry": "DK"
  },
  "openingHoursSpecification": [
    {
      "@type": "OpeningHoursSpecification",
      "dayOfWeek": [
        "Monday",
        "Tuesday",
        "Wednesday",
        "Thursday",
        "Friday"
      ],
      "opens": "09:00",
      "closes": "17:00"
    }
  ]
}
</script>